These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12712489)

  • 1. Clinical and biologic significance of nuclear unrest in Wilms tumor.
    Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS
    Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
    Salama A; Kamel A
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.
    Dome JS; Liu T; Krasin M; Lott L; Shearer P; Daw NC; Billups CA; Wilimas JA
    J Pediatr Hematol Oncol; 2002; 24(3):192-8. PubMed ID: 11990305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors.
    Rakheja D; Khokhar S; Mitui M; Cost NG
    Pediatr Dev Pathol; 2012; 15(4):286-92. PubMed ID: 22483234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
    Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
    Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor. The St Jude Children's Research Hospital experience: 1999-2006.
    Davidoff AM; Giel DW; Jones DP; Jenkins JJ; Krasin MJ; Hoffer FA; Williams MA; Dome JS
    Cancer; 2008 May; 112(9):2060-70. PubMed ID: 18361398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.
    Teixeira RA; Odone-Filho V; de Camargo B; Zerbini MC; Fillipi R; Alencar A; Cristofani L
    Pediatr Hematol Oncol; 2011 Apr; 28(3):194-202. PubMed ID: 21214406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
    Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
    Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.
    Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M;
    Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
    Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
    J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group.
    Faria P; Beckwith JB; Mishra K; Zuppan C; Weeks DA; Breslow N; Green DM
    Am J Surg Pathol; 1996 Aug; 20(8):909-20. PubMed ID: 8712292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear morphometric analysis of metastasis in Wilms' tumor after multimodal therapy: comparison with primary tumor.
    Gearhart JP; Willmann JR; Beckwith JB; Epstein J; Partin AW
    Urology; 1995 Jan; 45(1):119-23. PubMed ID: 7817463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic protein expression in favorable-histology Wilms tumor correlates with tumor recurrence.
    Agarwal S; Iyer VK; Agarwala S; Mathur SR; Aron M; Datta Gupta S; Verma K
    Pediatr Surg Int; 2011 Mar; 27(3):303-8. PubMed ID: 20963425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020).
    Vujanić GM; Mifsud W; Chowdhury T; Al-Saadi R; Pritchard-Jones K;
    Cancer; 2022 Apr; 128(8):1666-1675. PubMed ID: 35119702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein expression in nephroblastomas: a predictor of poor prognosis.
    Govender D; Harilal P; Hadley GP; Chetty R
    Br J Cancer; 1998; 77(2):314-8. PubMed ID: 9461003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of Wilms' tumor trial (WT-99) in Shanghai children's medical center].
    Tang JY; Pan C; Xu M; Xue HL; Chen J; Zhao HL; Gu LL; Wang YP
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):131-4. PubMed ID: 14759320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.